Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol;Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC

Pathologie Biologie

Volumn 52, Issue 9 SPEC.ISS., 2004, Pages 522-528

  Pivert, A ^a   Payan, C ^a   Lunel, F ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Antig ne de capside; ARN; Cin tiques virales; Co infection HCV HIV; Co infection VHC VIH; Core antigen; Corr lation; Correlation; Quantifications; RNA; Viral kinetics

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; PEGINTERFERON; RIBAVIRIN; VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MICROBIAL KINETICS; MOLECULAR EVOLUTION; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; TREATMENT OUTCOME; VIROLOGY; VIRUS DETECTION; VIRUS VIRULENCE;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2B; INTERFERONS; REPRODUCIBILITY OF RESULTS; RIBAVIRIN; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 8744243439     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.07.036     Document Type: Article

References (23)

1. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 4902 1989 359 362
2. S.M. Feinstone, K.B. Mihalik, T. Kamimura, H.J. Alter, W.T. London, and R.H. Purcell Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform Infect. Immun. 41 2 1983 816 821
3. L.F. He, D. Alling, T. Popkin, M. Shapiro, H.J. Alter, and R.H. Purcell Determining the size of non-A, non-B hepatitis virus by filtration J. Infect. Dis. 156 4 1987 636 640
4. K.E. Reed, and C.M. Rice Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties Curr. Top. Microbiol. Immunol. 242 2000 55 84
5. M.E. Major, and S.M. Feinstone The molecular virology of hepatitis C Hepatology 25 6 1997 1527 1538
6. R. De Francesco, A. Urbani, M.C. Nardi, L. Tomei, C. Steinkuhler, and A. Tramontano A zinc binding site in viral serine proteinases Biochemistry 35 41 1996 13282 13287
7. F. Lunel, L. Stuyver, C. Brechot, and G. Maertens Mise au point sur le virus de l'h́patite C: variabilit́ et implications Transfus. Clin. Biol. 5 1998 147 165
8. J. Gomez, M. Martell, J. Quer, B. Cabot, and J.I. Esteban Hepatitis C viral quasispecies J. Viral Hepa. 6 1 1999 3 16
9. A. Manzin, L. Solforosi, M. Debiaggi, F. Zara, E. Tanzi, and L. Romano Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection J. Virol. 74 9 2000 4327 4334
10. G. Lauer, and B. Walker Hepatitis C Virus infection N Engl. J. Med. 345 2001 41 52
11. J.F. Delfraissy HIV infection 2002. Progress and limits Revue de Ḿdecine Interne 23 Suppl 5 2002 529 531
12. S. Pol, and H. Zylberberg Interactions entre les virus de l'immunod́ficience humaine et de l'h́patite:C Rev. Med. Interne 19 1998 885 891
13. H. Zylberberg, and S. Pol Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections Clin. Infect. Dis. 23 5 1996 1117 1125
14. S. Sauleda, A. Juarez, J.I. Esteban, C. Altisent, I. Ruiz, L. Puig, R. Esteban, and J. Guardia Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders Hepatology 34 5 2001 1035 1040
15. M. Perez-Olmeda, J. Gonzalez, J. Garcia-Samaniego, J.R. Arribas, J.M. Pena, and V. Soriano Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C Journal of Acquire Immune Deficiency Syndrome 22 3 1999 308 309
16. A. Landau, D. Batisse, C. Piketty, J.P. Duong Van Huyen, F. Bloch, and L. Belec Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients AIDS 15 16 2001 2149 2155
17. G. Morsica, A. De Bona, C.U. Foppa, G. Sitia, R. Finazzi, and A. Lazzarin Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment AIDS 14 11 2000 1656 1658
18. G. Nasti, G. Di Gennaro, M. Tavio, L. Cadorin, R.M. Tedeschi, and R. Talamini Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and ribavirin AIDS 15 14 2001 1783 1787
19. P. Ferenci Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies Journal of Antimicrobial Chemotherapy 53 1 2004 15 18
20. F. Lunel, P. Veillon, I. Fouchard-Hubert, V. Loustaud-Ratti, A. Abergel, C. Silvain Fontevraud Study Group Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen Journal of Hepatology 39 5 2003 826 833
21. P. Veillon, C. Payan, G. Picchio, M. Maniez-Montreuil, P. Guntz, and F. Lunel Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy Journal of Clinical Microbiology 41 7 2003 3212 3220
22. G. Squadrito, G. Raffa, T. Restuccia, T. Pollicino, S. Brancatelli, and G. Raimondo Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? Journal of Viral Hepatitis 9 5 2002 360 369
23. G.W. Witherell, and P. Beineke Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response Journal of Medical Virology 63 1 2001 8 16